FILED UNDER SOMETHINGISRAELI >> Health & Lifestyle
A way to test for the Hepatitis C virus (HCV) through saliva in the month, rather than a blood test has been developed by an Israeli company and is proving to be an effective way for detection of the HCV.
In developing countries of the world including those in Africa where blood tests are expensive and not readily available, a saliva test is a lower-cost option that can help.
Towards the end of last year, these findings were reported in the influential publication Journal of Virological Methods based on research undertaken by a number of leading doctors in Israel from Soroka University Medical Centre, Rambam Medical Centre, Wolfson Medical Centre, Bnai-Zion Medical Centre and Ben-Gurion University of the Negev. The researchers were led by Arieh Yaari of the Soroka University Medical Centre
The initial research was conducted on 37 dialysis patients using the ImmunoComb II to test the saliva which was developed by Orgenics but a larger scale study is needed to further prove the success of this method to test for HCV.
Orgenics, a company that has been developing screening and other medical related products since 1982, is owned of Inverness Medical Innovations. Inverness has interests in a wide range of medical services and owns Unipath, the company which develops products for women's health including pregnancy test Clearblue.
Last month, the Yavne-based company was selected by the former US president Bill Clinton's foundation as a supplier of HIV diagnostic tests to the foundation's member countries under its HIV/AIDS Initiative program.
"We are proud to join the Clinton Foundation in its efforts to bring affordable HIV diagnostic testing to resource-poor countries. Orgenics' selection by the Clinton Foundation, along with our recent acquisition from Abbott Laboratories of the popular Determine line of HIV products, confirm our position as a worldwide leader in HIV rapid diagnostics."
For more information: www.orgenics.com